Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Oliver Reeves, chief financial officer of Surf Air Mobility Inc (NYSE: SRFM), sold 28,874 shares on April 16, 2026 at $1.3055 per share for $37,695 to meet tax withholding obligations tied to restricted stock units. The sale occurred amid recent stock volatility and follows a reported Q4 2025 revenue miss; the company has nonetheless posted three s…
Magnetar Financial LLC and affiliated entities sold 1,401,752 shares of CoreWeave, Inc. (CRWV) Class A common stock on April 16, 2026, generating proceeds of $166.17 million at prices between $117.96 and $120.64 per share. The stock now trades at $116.85, just below the sale range. The share disposal occurs alongside CoreWeave's $6 billion capacity…
Aehr Test Systems director Fariba Danesh sold 8,000 shares on April 16, 2026, for $661,040 and exercised options to acquire 8,000 shares the same day. The transactions come amid a year of dramatic stock appreciation and the company’s announcement of a record $41 million production order for package-level burn-in of custom AI processor ASICs, alongs…
Affiliates of Magnetar reported selling CoreWeave, Inc. (NASDAQ: CRWV) Class A common stock on April 15, 2026, in multiple transactions that together totaled $309,022,617. The trades occurred across a range of prices and follow a period of strong share-price appreciation for CoreWeave alongside a sizable strategic investment and a new senior note o…
Magnetar Financial LLC and affiliated entities disposed of 241,802 shares of CoreWeave, Inc. (CRWV) Class A common stock on April 15, 2026, generating roughly $50.1 million in proceeds. The trades occurred in a price band between $117.79 and $119.34. CoreWeave shares are trading near $116.85 and have gained 199% over the last 12 months, with a plat…
System1, Inc. Chief Financial Officer Tridivesh Kidambi purchased 26,910 Class A shares on April 15, 2026, at $3.00 per share, a transaction valued at $80,730. The acquisition occurred while System1's stock was trading at $2.15 and after marked declines over the past week and six months. The company also posted supplemental fourth-quarter 2025 fina…
Aehr Test Systems director Rhea J. Posedel reported the sale of 7,500 shares on April 17, 2026, for $82.00 per share, a transaction valued at $615,000. The sale occurred as the stock has climbed substantially over the past year and follows company announcements of a record $41 million production order and mixed Q3 2026 financial results that left b…
Kevin J. O’Connor, a director of Procore Technologies (PCOR), disposed of 11,538 shares in four transactions on April 15 and 16, 2026, under a 10b5-1 trading plan. The sales totaled $602,485. After the transactions, O’Connor retains substantial holdings both directly and through a revocable trust. The company recently posted Q4 2025 results that be…
Klaviyo Chief Financial Officer Amanda Whalen sold 14,000 shares of Series A common stock on April 16, 2026, for $259,560 under a Rule 10b5-1 plan. The transaction coincided with share conversions and recent equity awards to Whalen, while the company unveiled a $500 million buyback program and product enhancements. Analysts have adjusted price targ…
Aehr Test Systems director Howard T. Slayen sold 25,000 shares on April 17, 2026, for $85.00 each, a transaction totaling $2,125,000, according to a Form 4 filing. The sale leaves Slayen with 178,328 directly held shares including unvested restricted stock units. The transaction arrives as AEHR shares trade near $83.86 after a one-year gain of 937%…
Ugwumba Chidozie, who holds a ten percent stake in Clene Inc. (NASDAQ: CLNN), disposed of 39,162 shares of common stock in three transactions from April 15 to April 17, 2026, generating proceeds of $251,897. After the sales, Chidozie continues to indirectly own 362,729 shares through SymBiosis II, LLC. The share sales occurred as CLNN has returned …
Director Laura Oliphant sold 1,716 shares of Aehr Test Systems common stock on April 16, 2026, for $81.54 per share, generating proceeds of $139,922, according to a Form 4 filing. After the sale Oliphant directly holds 16,716 shares, including unvested restricted stock units. The firm reported a record $41 million production order for package-level…
Malisa Chambliss, StandardAero's Chief Human Resources Officer, sold 764 shares of the company on April 16, 2026, generating about $20,903. The sale followed an options exercise the prior day and occurred while the stock was trading below the transaction price. The aerospace services provider reported record fourth-quarter 2025 results, and recent …
Daniella Ballou-Aares, a director at IBEX Ltd (NASDAQ: IBEX), sold $162,809 worth of common shares across transactions in March and December 2025. The director now holds 10,643 shares. The stock trades at $29.72, down roughly 18% over six months, while InvestingPro flags a P/E of 9.8 and notes management share repurchases. IBEX reported stronger-th…
Apogee Therapeutics CFO Jane Henderson sold 2,000 shares on April 16, 2026, for $90.00 per share, generating $180,000 in proceeds. The transaction was executed through a Rule 10b5-1 trading plan. The stock has climbed roughly 178% over the past year and sits close to its 52-week high. Apogee also completed a $403 million underwritten offering and p…
Gregory Clemens Krekeler, President of Component Repair Services at StandardAero, sold 390 shares of company common stock on April 16, 2026, for $27.36 per share, totaling $10670. The transaction follows a series of equity grants and option exercises on April 15 and comes as the company reports record fourth-quarter 2025 results and receives mixed …
Anthony Brancato, President of Engine Services - Business Aviation at StandardAero, sold 1,107 shares on April 16, 2026, to satisfy tax withholding tied to RSU vesting after exercising options. The transaction and recent corporate developments come as analysts revise forecasts amid solid Q4 2025 results and a planned management succession.
Prebble Lewis, President of Engine Services - Airlines & Fleets at StandardAero, Inc. (EXCHANGE:SARO), sold 1,141 shares on April 16, 2026, for $27.36 per share, totaling $31,217. The transaction followed an acquisition of 4,147 shares on April 15. StandardAero recently disclosed record fourth-quarter 2025 results and has seen varying analyst r…
StandardAero Chief Strategy Officer Alex Trapp sold 475 shares on April 16, 2026, for $27.36 each, a transaction totaling $12,996. The trade occurred while SARO shares traded at $26.76, down 6.7% year-to-date, even though InvestingPro’s Fair Value estimate places the stock at $31.68. Trapp also executed stock-related acquisitions on April 15, 2026,…
StandardAero Chief Operating Officer Kimberly Ernzen sold 2,516 shares on April 16, 2026, for $68,837 to satisfy tax withholding tied to restricted stock unit vesting. The move accompanied option exercises and receipt of additional equity awards, while the company reported record fourth-quarter 2025 results and saw mixed analyst actions on price ta…
Marc Drobny, President of Engine Services - Military, Helicopters & Energy at StandardAero, sold 1,094 shares on April 16, 2026, while initiating and receiving multiple equity awards the prior day. The transactions occur against a backdrop of record fourth-quarter 2025 results and recent analyst updates and leadership changes at the company.
Vernon Rogers, Executive Vice President of Sales & Marketing at Aehr Test Systems (NASDAQ:AEHR), sold 5,000 shares on April 16, 2026, at $86.88 per share for $434,400. The company meanwhile reported a record $41 million production order, robust quarterly bookings and a backlog above $50 million, alongside mixed Q3 2026 financials and updated an…
StandardAero finance chief Daniel Satterfield reported a sale of 2,306 common shares on April 16, 2026, at $27.36 per share for $63,092, one day after acquiring 8,538 shares. The company recently posted record fourth-quarter 2025 results and has drawn varied analyst attention, while investing-platform commentary flags the stock as undervalued.
StandardAero Chief Executive Officer Ford Russell Wayne sold 10,638 shares on April 16, 2026, at $27.36 per share for roughly $291,055 to cover tax withholding tied to vested RSUs. The filing also shows simultaneous exercises and awards that expanded his equity position. The company reported record Q4 2025 revenue and EPS, while analysts adjusted m…
Revolution Medicines' CEO Mark A. Goldsmith sold 120,000 shares on April 15, 2026, realizing $18,010,488 at $150.0874 per share and simultaneously exercised 120,000 options. The transactions leave him with both direct and indirect holdings, while the company completed about $2.1 billion in concurrent equity and convertible note offerings and disclo…
